Posted on Leave a comment

RNA interference Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Moderna Therapeutics, GenSight Biologics, Pfizer, bluebird bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, RNA interference pipeline constitutes 20+ key companies continuously working towards developing 90+ RNA interference treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The RNA interference Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]

Posted on Leave a comment

Exploring Advancements in Chronic Lymphocytic Leukemia Pipeline, 2023 Updates | Recent FDA, EMA, and PMDA Approvals | Sana Biotechnology, Novartis, Janssen Research, NovalGen, Genmab

Chronic Lymphocytic Leukemia Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Lymphocytic Leukemia pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Chronic Lymphocytic Leukemia Pipeline report embraces in-depth […]

Posted on Leave a comment

Soft Tissue Sarcoma Market: Breakthrough Forecast Study Predicts Astounding Growth in the Upcoming Years | Philogen, Gradalis, Epizyme, CytRx, KaryoPharm, Nanobiotix, Apexigen, Lytix, Incyte, Iovance

Delveinsight Business Research LLP As per DelveInsight, the Soft Tissue Sarcoma Market is anticipated to evolve immensely in the coming years owing to the extensive research and development activities of pharmaceutical companies, along with the launch of various therapies, and the rise in the number of cases of Soft Tissue Sarcoma. The number of clinical […]

Posted on Leave a comment

Knee Osteoarthritis Pipeline Medications (2023): FDA Approvals, Clinical Trials, Therapeutic Approaches, Mechanisms of Action, and Administration Routes by DelveInsight | Eupraxia Pharma, Techfields

Knee Osteoarthritis Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Knee Osteoarthritis pipeline constitutes 40+ key companies continuously working towards developing 40+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   The Knee Osteoarthritis Pipeline report embraces in-depth commercial and clinical […]

Posted on Leave a comment

Vaccine Adjuvants Market worth $1.2 billion | MarketsandMarkets

In May 2023 Croda International Plc (UK) entered into a partnership with Amyris (US) and Botanical Solutions Inc. (BSI) firstly for biotechnology-derived squalene and secondly with BSI for develop a sustainable QS-21 vaccine adjuvant moving towards plant tissue culture-derived approach rather than traditional method of extracting QS-21 from soap bark trees. The vaccine adjuvants industry […]

Posted on Leave a comment

US Healthcare Technology Management Market worth $17.3 billion | MarketsandMarkets

Prominent players in the US healthcare technology management market are GE Healthcare (US), TRIMEDX (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Sodexo (France) Browse 30 market data Tables and 38 Figures spread through 122 Pages and in-depth TOC on “US Healthcare Technology Management Market by Service (Maintenance & Repair, Integrated software platform, Quality & […]

Posted on Leave a comment

Surgical Robots Market worth $18.4 billion by 2027

Intuitive Surgical (US), Stryker Corporation (US), Medtronic Plc (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc. (UK) are key players in the surgical robots market. The Asia Pacific surgical robots market is expected to grow at the highest CAGR […]

Posted on Leave a comment

CRISPR Market Industry Analysis, Trends, Key Highlights, Future Scope, and Leading Players – 2028

The Asia Pacific CRISPR market is projected to grow at the highest CAGR during the forecast period, mainly due to increasing awareness of the importance of the research and development activities in the healthcare industry, large patient population, and advancements in sequencing technologies. CRISPR Market in terms of revenue was estimated to be worth $3.4 […]

Posted on Leave a comment

Growth Anticipated in Plasma Cell Leukemia Market Over 2023-2032, DelveInsight’s Analysis | Spotlight on Key Players – Denovo Biopharma, Orbus Therapeutics, and Genetech

Plasma Cell Leukemia Market (Albany, USA) DelveInsight’s “Plasma Cell Leukemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Plasma Cell Leukemia, historical and forecasted epidemiology as well as the Plasma Cell Leukemia market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.   To Know in […]

Posted on Leave a comment

ESR1-mutated Metastatic Breast Cancer Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Eisai, Roche, AstraZeneca, Sun Pharma, Arvinas

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, ESR1-mutated Metastatic Breast Cancer pipeline constitutes key companies continuously working towards developing ESR1-mutated Metastatic Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The ESR1-mutated Metastatic Breast Cancer Pipeline report embraces in-depth commercial and clinical […]